Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

Status:
Recruiting

Trial end date:
2022-06-30

Target enrollment:

Participant gender:

This study will evaluate whether EVO100 vaginal gel prevents the sexual transmission of CT and GC infection

Phase 3

Evofem Inc.